25 of the Best Oncologists Near Me

Dr. Jennifer Ligibel is a Professor at Harvard Medical School, the Director of the Leonard P. Zakim Center for Integrative Therapies and Healthy Living, and the Director of the Center for Faculty Well-Being at the Dana-Farber Cancer Institute. Dr. Ligibel’s research focuses on the impact of lifestyle interventions upon cancer-related outcomes in women with breast cancer. She has conducted a number of studies looking at the impact of exercise and weight loss interventions upon patients’ quality of life and symptoms after cancer diagnosis and is currently leading an NCI-funded Phase III clinical trial that will test the impact of a weight loss intervention upon the risk of disease recurrence in more than 3000 overweight and obese women with early-stage breast cancer. Dr. Ligibel was the Chair of the American Society of Clinical Oncology Subcommittee on Energy Balance, which has developed patient and physician materials to help facilitate healthy lifestyle changes after cancer diagnosis. Dr. Ligibel is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Hormone Replacement Therapy (HRT). Dr. Ligibel is board certified in Medical Oncology. Dr. Ligibel is currently accepting new patients.

Marina Baretti, MD, is an assistant professor at Johns Hopkins University School of Medicine and the Jiasheng Chair in Hepato-Biliary Cancer Research. She also serves as Co-Director of the Liver and Biliary Cancer Multidisciplinary Clinic at the Sidney Kimmel Comprehensive Cancer Center (SKCCC). Dr. Baretti received her medical degree from the University of Pisa in Italy. She completed her internal medicine residency and oncology fellowship at University of Milan. She then went on and completed her Postdoctoral and Medical Oncology Fellowship at Johns Hopkins University, Baltimore, Maryland. She is deeply engaged in bridging the gap between laboratory discoveries and clinical application, working closely with laboratory-based scientists to accelerate the development of novel therapeutic strategies. Her academic research is centered on the development of novel agents in hepatobiliary cancers, with particular interest in combinatorial approaches of immunotherapies. She is currently the principal investigator on multiple clinical trials in FLC, HCC and cholangiocarcinoma at Johns Hopkins University, collaborating closely with laboratory-based researchers to move laboratory findings into patients. Through her work, Dr. Baretti strives to improve outcomes for patients with rare GI cancers by identifying innovative therapies that are informed by a deeper understanding of tumor biology and the tumor microenvironment. Dr. Baretti was the recipient of the 2018 American Society of Clinical Oncology Young Investigator Award. Dr. Baretti was also awarded with the 2020 Career Development Award for the MD Anderson Cancer Center’s pancreatic cancer NCI Specialized Programs of Research Excellence (SPORE). Dr. Baretti is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, and Pancreatic Cancer. Dr. Baretti is currently accepting new patients.

Charles Geyer, MD, specializes in breast medical oncology and is certified in medical oncology and internal medicine by the American Board of Internal Medicine. He practices at the UPMC Magee Womens Hospital. He completed his medical degree at Texas Tech University Health Science Center, residency at Baylor College of Medicine, chief residency at Baylor College of Medicine and medical oncology fellowship at Baylor College of Medicine. Dr. Geyer is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Febrile Neutropenia, and Menopause. Dr. Geyer is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Geyer is currently accepting new patients.

Dr. Diamond is a hematologist/oncologist who specializes in the treatment of plasma cell disorders including monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma. His research interests include utilization of minimal residual disease (MRD)-guided approaches to clinical decision-making, maintenance therapy, and the genomics of multiple myeloma and secondary malignancies that occur in patients treated for multiple myeloma. He completed fellowship at Memorial Sloan Kettering Cancer Center, spending a year as chief fellow, and is a member of the Myeloma Genomics Laboratory at Sylvester Comprehensive Cancer Center. Dr. Diamond is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Relapsed Refractory Multiple Myeloma (RRMM). Dr. Diamond is currently accepting new patients.

Alejandra Perez is an Oncologist practicing medicine in Plantation, Florida. Dr. Perez is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and Breast Cancer. Dr. Perez is currently accepting new patients.

Carol Karp is an Oncologist practicing medicine in Miami, Florida. Dr. Karp is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Melanoma of the Eye, Lymphoid Hyperplasia, Melanoma, Trabeculectomy, and Cataract Removal. Dr. Karp is currently accepting new patients.

Christie Hancock is a Hematologist and an Oncologist practicing medicine in Park Ridge, Illinois. Dr. Hancock is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Inflammatory Breast Cancer. Dr. Hancock is board certified in American Board Of Internal Medicine, Hematology. Dr. Hancock is currently accepting new patients.

Prashant Joshi is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Joshi is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Breast Cancer. Dr. Joshi is board certified in American Board Of Internal Medicine, Hematology. Dr. Joshi is currently accepting new patients.

Suchin Khanna is a Hematologist and an Oncologist practicing medicine in Downers Grove, Illinois. Dr. Khanna is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Khanna is board certified in American Board Of Internal Medicine, Hematology. Dr. Khanna is currently accepting new patients.

Philosophy of care | I believe children are a unique population of patients that require a physician dedicated to their well-being. I believe they are vulnerable and often unable to speak up for themselves. I believe that each child and family should be treated as if they are my own relation. | Why I entered medicine | I entered medicine for the satisfaction of being able to help and offer hope to those who are ill. I chose pediatric hematology oncology because these children have a serious illness and their parents are at the lowest point of their lives, and I can provide them with hope and compassion. | Community involvement | I volunteer at Camp Dost, a camp for children with cancer. Since 2003 I have helped there, and love seeing how this experience helps kids who are dealing with cancer enjoy time just being kids. | Personal interests | I enjoy many types of sports, but specifically like basketball, baseball, football, and golf. I also like to go canoeing and doing physical fitness activities. Dr. Troutman is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Sickle Cell Disease, Thalassemia, Hemoglobin SC Disease, and Bone Marrow Aspiration. Dr. Troutman is board certified in American Board Of Pediatrics - Pediatrics and American Board Of Pediatrics - Pediatric Hematology-Oncology . Dr. Troutman is currently accepting new patients.

Dr. Ahrendt is a board certified medical oncologist originally from Boston, Massachusetts. She earned a bachelor's degree in biology from Washington University in St. Louis, Missouri, followed by a medical degree from the Drexel University Hahnemann School of Medicine in Philadelphia, Pennsylvania. Dr. Ahrendt completed an internship, residency and a combined hematology/oncology fellowship at Tufts New England Medical Center in Boston. Dr. Ahrendt pursued a career in medicine because of her desire to help those in need and being able to make an impact on people’s ability to get through disease and difficult situations.“The key to successful treatment of cancer is having a team-based approach. The relationship between the patient, family members, doctors, nurses and support services is so important.”  Dr. Ahrendt’s clinical interests include breast cancer, colorectal cancer, lung cancer, chronic myeloid leukemia (CML), and chronic lymphocytic leukemia (CLL). Dr. Ahrendt is an investigator involved in clinical research trials in the areas of medical oncology and hematology. Her research includes oncology and hematology. She has been practicing oncology in Denver since 2004 and is currently accepting new patients. When she is not at work, Dr. Ahrendt enjoys skiing, camping, hiking and fishing with her husband and son. Dr. Ahrendt is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Ahrendt is board certified in American Board Of Internal Medicine. Dr. Ahrendt is currently accepting new patients.

Magdalena Flejsierowicz is a Hematologist and an Oncologist practicing medicine in Milwaukee, Wisconsin. Dr. Flejsierowicz is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and Breast Cancer. Dr. Flejsierowicz is board certified in American Board Of Internal Medicine, Hematology. Dr. Flejsierowicz is currently accepting new patients.

Emmanouil Alimpertis is a Hematologist and an Oncologist practicing medicine in Marinette, Wisconsin. Dr. Alimpertis is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Neuroendocrine Tumor, Midline Lethal Granuloma, T-Cell Lymphoma, and Splenectomy. Dr. Alimpertis is board certified in American Board Of Internal Medicine, Hematology. Dr. Alimpertis is currently accepting new patients.

Rudy Suidan is an Oncologist practicing medicine in Aurora, Illinois. Dr. Suidan is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Malignant Mixed Mullerian Tumor, Lymphadenectomy, and Splenectomy. Dr. Suidan is board certified in American Board Of Obstetrics & Gynecology, Gynecologic Oncology. Dr. Suidan is currently accepting new patients.

Mousami Shah is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Shah is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Breast Cancer in Men. Dr. Shah is board certified in American Board Of Internal Medicine, Hematology. Dr. Shah is currently accepting new patients.

I provide comprehensive care to women with gynecologic malignancies and pre-malignancy conditions, including both surgical management and chemotherapy/medical management. I specialize in minimally invasive surgeries including both robotic and traditional laparoscopic surgeries. My treatment philosophy is that each patient is a unique individual and her treatment plan should be individualized to her specific needs. Dr. Turker is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Endometrial Stromal Sarcoma, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Salpingo-Oophorectomy, and Bladder Reconstruction. Dr. Turker is board certified in American Board Of Obstetrics/Gynecology, Obstetrics & Gynecology and American Board Of Obstetrics/Gynecology, Gynecologic Oncology. Dr. Turker is currently accepting new patients.

"Sohaip Kabashneh, MD is a dedicated hematology/oncology physician at Intermountain Health’s Cancer Center – Utah Valley in Provo, Utah. He supports patients in Provo, Orem, Vineyard, Springville, and surrounding communities providing care in breast cancer, lung cancer, prostate cancer, gastrointestinal cancers, and more. He is excited to bring his specialties in medical oncology, benign hematology, and malignant hematology to his patients at Intermountain Health. His philosophy of care is rooted in the belief that ""The good physician treats the disease; the great physician treats the patient who has the disease."" This principle guides his approach to patient care, emphasizing the importance of understanding each individual's needs.Dr. Kabashneh is committed to patient education and fostering a culture of shared decision-making. When his patients collaborate with him, he wants them to feel informed and empowered to make the best choices for their health.Outside the clinic, the Jordan native enjoys spending quality time with his wife and daughter and taking walks to relax and recharge.Conditions Treated: Breast cancerLung cancerProstate cancerGastrointestinal cancersSkin cancer including melanoma, basal cell carcinoma - Different types of Anemias and clotting disordersLymphomaMultiple MyelomaMyelodysplasiaProcedures Performed: Bone marrow biopsiesLumbar puncture". Dr. Kabashneh is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Leukocytosis, Scleromyxedema, Papular Mucinosis, Mesenteric Venous Thrombosis, and Coronary Artery Bypass Graft (CABG). Dr. Kabashneh is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Kabashneh is currently accepting new patients.

Mark Faries is an Oncologist and a Surgical Oncologist practicing medicine in Los Angeles, California. Dr. Faries is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Squamous Cell Skin Carcinoma, and Lymphadenectomy. Dr. Faries is currently accepting new patients.

Ravi Amaravadi is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Amaravadi is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Neural Crest Tumor, Tissue Biopsy, and Liver Embolization. Dr. Amaravadi is board certified in Medical Oncology, 2006. Dr. Amaravadi is currently accepting new patients.

"It is my personal goal that every patient that we see feels that they are receiving optimal care here at Duke. My focus is to provide each patient with ""cutting-edge"" treatments, and to do so in a compassionate and thoughtful manner.". Dr. Hanks is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, and Metastatic Uveal Melanoma. Dr. Hanks is board certified in American Board Of Internal Med, Internal Medicine. Dr. Hanks is currently accepting new patients.

Yana G. Najjar, MD is a translational investigator and cutaneous oncologist at UPMC Hillman Cancer Center, where she also is an associate professor of medicine and Director of the Clinical and Translational Research Center. Dr. Najjar specializes in early phase clinical trials and in the treatment of advanced melanoma. Her research focusing on immunotherapy resistant melanoma and rare melanoma subtypes. She has developed multiple investigator-initiated trials that aim to remodel melanoma tumor cell metabolism and hypoxia in the tumor microenvironment to overcome mechanisms of resistance to immunotherapy. Her lab is focused on various correlative analyses from investigator-initiated trials. Dr. Najjar's research is funded by the NIH, the Department of Defense, and the Melanoma Research Alliance. Dr. Najjar is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Melanoma, Metastatic Uveal Melanoma, Melanoma of the Eye, Renal Cell Carcinoma (RCC), and Gamma Knife Radiosurgery. Dr. Najjar is board certified in American Board Of Internal Medicine. Dr. Najjar is currently accepting new patients.

Michael Postow is an Oncologist practicing medicine in New York, New York. Dr. Postow is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Melanoma, Metastatic Uveal Melanoma, Alopecia Universalis, Eosinophilic Fasciitis, and Liver Embolization. Dr. Postow is currently accepting new patients.

Victoria Seewaldt is an Oncologist practicing medicine in Duarte, California. Dr. Seewaldt is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, and HER-2 Positive Breast Cancer.

I believe that all patients and their caregivers expect and deserve close attention to issues that are affecting their quality of life. As an oncologist (cancer doctor) and palliative medicine physician, I aim to make the experience of going through serious cancer less distressful, adding in an extra layer of support. Dr. Kamal is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Breast Cancer, and Pancreatic Cancer. Dr. Kamal is board certified in American Board Of Internal Med, Hospice & Palliative Medicine. Dr. Kamal is currently accepting new patients.

Debasish Tripathy is an Oncologist practicing medicine in Cary, North Carolina. Dr. Tripathy is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma.